SLP241220C60000
- 0.40
- 0.000.00%
Simulations Plus Newsroom
Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar?
Simulations Plus to Participate in the BTIG Digital Health Forum
Stephens Initiates Simulations Plus(SLP.US) With Buy Rating, Announces Target Price $39
Simulations Plus Initiated With an Overweight at Stephens
FDA Grants Simulations Plus to Use PBPK to Expand Mechanistic Modeling for LAI
We Think Simulations Plus' (NASDAQ:SLP) Solid Earnings Are Understated
Simulations Plus Insider Sold Shares Worth $553,200, According to a Recent SEC Filing
Simulations Plus | 10-K: FY2024 Annual Report
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
Simulations Plus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
BTIG Maintains Simulations Plus(SLP.US) With Buy Rating, Cuts Target Price to $50
Express News | William Blair Reiterates Outperform on Simulations Plus
Simulations Plus Is Maintained at Buy by BTIG
Simulations Plus Analyst Ratings
Express News | Simulations Plus Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Revenue Results
Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating, Announces Target Price $56
Simulations Plus Price Target Lowered to $50 From $60 at BTIG
JMP Securities Maintains Simulations Plus(SLP.US) With Hold Rating
JMP Securities Reaffirms Their Hold Rating on Simulations Plus (SLP)
Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript Summary